March 2024 iConquerMS Spotlight
How effective are COVID-19 vaccines in people with MS?
The iConquerMS community has contributed to many research studies on a wide variety of topics, including COVID-19 vaccines and how they work in people affected by MS.
The COVER-MS study shows the frequency of vaccination reactions in people with MS is similar to that reported in the COVID-19 vaccine clinical trials.
Want to learn more about what we’ve learned from COVER-MS so far?
Visit the COVER-MS Data Dashboard
Watch Chat with Chat, Episode 4
See an overview of COVER-MS results
Through a partnership with Quest Diagnostics and the National MS Society, a COVER-MS sub-study is looking at the effectiveness of COVID-19 vaccines at preventing the virus in people with MS. As part of this effort, 300 COVER-MS participants are donating blood every 6 months over a 2-year period. These samples are being analyzed to determine how MS drugs and other factors affect the immune response (antibody levels) to COVID-19. Stay tuned for these results!
iConquerMS brings together people with MS, their care partners, researchers and others to understand MS and search for solutions. If you haven’t already, please consider joining today!
